Matches in SemOpenAlex for { <https://semopenalex.org/work/W2186450107> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2186450107 endingPage "44" @default.
- W2186450107 startingPage "136" @default.
- W2186450107 abstract "Cystoid Macular Edema (CME) is one of the most common and sight threatening complications of uveitis. Intravitreal injection of corticosteroids and Anti-VEGF are two routine options for treatment.To compare the effects of intravitreal injections of Bevacizumab and Triamcinolone Acetonide for the treatment of persistent macular edema in non-infectious uveitis.In a randomized clinical trial, sixty eyes of 55 patients were enrolled in the study. Patients were divided into two groups with randomized digits table. 29 eyes received 4 mg of intravitreal triamcinolone acetonide, and 31 eyes received 1.25 mg of intravitreal bevacizumab. Two main outcome measures were changes in visual acuity, measured with logarithm of minimal angle of resolution, and central macular thickness, measured with optical coherence tomography.The mean follow-up was 25.3 weeks. The best visual acuities were achieved 6 months after injection in both groups. Improvement in visual acuity at 6 months was achieved in 28/29 (96%) of eyes in Triamcinolone group and in 26/31 (83%) eyes in Bevacizumab group (p=0.196). None of the eyes showed worsening of visual acuity after 6 months. Mean of central macular thickness in the pre-injection time for intravitreal triamcinolone acetonide (IVTA) group was 295.62 μ, and 309.87 μ in intravitreal bevacizumab (IVB) group, which were decreased after six months to 199.27 μ and 221.06 μ, respectively (p<0.001).This study shows that IVT and IVB are both effective in improving vision in uveitic CME. Although effects of triamcinolone on Central Macular Thickness (CMT) are more apparent, this superiority is not seen on Best Corrected Visual Acuity (BCVA)." @default.
- W2186450107 created "2016-06-24" @default.
- W2186450107 creator A5024845374 @default.
- W2186450107 creator A5064177178 @default.
- W2186450107 creator A5065173566 @default.
- W2186450107 date "2012-06-01" @default.
- W2186450107 modified "2023-10-18" @default.
- W2186450107 title "Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema." @default.
- W2186450107 cites W1974863381 @default.
- W2186450107 cites W1978604833 @default.
- W2186450107 cites W1979534828 @default.
- W2186450107 cites W1999923240 @default.
- W2186450107 cites W2000155939 @default.
- W2186450107 cites W2010646982 @default.
- W2186450107 cites W2022758760 @default.
- W2186450107 cites W2027070255 @default.
- W2186450107 cites W2039654078 @default.
- W2186450107 cites W2042225844 @default.
- W2186450107 cites W2043710992 @default.
- W2186450107 cites W2047505247 @default.
- W2186450107 cites W2056043330 @default.
- W2186450107 cites W2059911025 @default.
- W2186450107 cites W2098646181 @default.
- W2186450107 cites W2119264351 @default.
- W2186450107 cites W2130718174 @default.
- W2186450107 cites W2134178766 @default.
- W2186450107 cites W2135333970 @default.
- W2186450107 cites W2139499737 @default.
- W2186450107 cites W2151486474 @default.
- W2186450107 cites W2161433375 @default.
- W2186450107 cites W2416425822 @default.
- W2186450107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22735801" @default.
- W2186450107 hasPublicationYear "2012" @default.
- W2186450107 type Work @default.
- W2186450107 sameAs 2186450107 @default.
- W2186450107 citedByCount "4" @default.
- W2186450107 countsByYear W21864501072015 @default.
- W2186450107 countsByYear W21864501072016 @default.
- W2186450107 countsByYear W21864501072017 @default.
- W2186450107 countsByYear W21864501072022 @default.
- W2186450107 crossrefType "journal-article" @default.
- W2186450107 hasAuthorship W2186450107A5024845374 @default.
- W2186450107 hasAuthorship W2186450107A5064177178 @default.
- W2186450107 hasAuthorship W2186450107A5065173566 @default.
- W2186450107 hasConcept C118487528 @default.
- W2186450107 hasConcept C141071460 @default.
- W2186450107 hasConcept C2776194053 @default.
- W2186450107 hasConcept C2776251621 @default.
- W2186450107 hasConcept C2776694085 @default.
- W2186450107 hasConcept C2777802072 @default.
- W2186450107 hasConcept C2778257484 @default.
- W2186450107 hasConcept C2778903070 @default.
- W2186450107 hasConcept C2780347916 @default.
- W2186450107 hasConcept C71924100 @default.
- W2186450107 hasConceptScore W2186450107C118487528 @default.
- W2186450107 hasConceptScore W2186450107C141071460 @default.
- W2186450107 hasConceptScore W2186450107C2776194053 @default.
- W2186450107 hasConceptScore W2186450107C2776251621 @default.
- W2186450107 hasConceptScore W2186450107C2776694085 @default.
- W2186450107 hasConceptScore W2186450107C2777802072 @default.
- W2186450107 hasConceptScore W2186450107C2778257484 @default.
- W2186450107 hasConceptScore W2186450107C2778903070 @default.
- W2186450107 hasConceptScore W2186450107C2780347916 @default.
- W2186450107 hasConceptScore W2186450107C71924100 @default.
- W2186450107 hasIssue "2" @default.
- W2186450107 hasLocation W21864501071 @default.
- W2186450107 hasOpenAccess W2186450107 @default.
- W2186450107 hasPrimaryLocation W21864501071 @default.
- W2186450107 hasRelatedWork W1012944513 @default.
- W2186450107 hasRelatedWork W1524567005 @default.
- W2186450107 hasRelatedWork W2000573532 @default.
- W2186450107 hasRelatedWork W2070126836 @default.
- W2186450107 hasRelatedWork W2130235373 @default.
- W2186450107 hasRelatedWork W2171529843 @default.
- W2186450107 hasRelatedWork W2186450107 @default.
- W2186450107 hasRelatedWork W2384713826 @default.
- W2186450107 hasRelatedWork W2386947472 @default.
- W2186450107 hasRelatedWork W3032559858 @default.
- W2186450107 hasVolume "9" @default.
- W2186450107 isParatext "false" @default.
- W2186450107 isRetracted "false" @default.
- W2186450107 magId "2186450107" @default.
- W2186450107 workType "article" @default.